お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
934763

治療用血漿交換の世界市場 - 予測と機会:2025年

Global Therapeutic Plasma Exchange Market By Technique, By Indication, By Gender, By End Use, By Region, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 112 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.15円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

治療用血漿交換の世界市場 - 予測と機会:2025年
出版日: 2020年05月01日
発行: TechSci Research
ページ情報: 英文 112 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

世界の治療用血漿交換市場は、予測期間中に活発な速度で成長すると予測されています。治療用血漿交換または血漿交換は、遠心分離または膜分離と呼ばれる技術の助けを借りて血液から血漿を分離することにより、血液を濾過し、血漿中に存在する有害な抗体を除去する手順です。体内の血液を交換するプロセスである治療用血漿交換または血漿交換療法は、慢性疾患の増加に伴う需要の大幅な増加を目の当たりにしています。たとえば、ギランバレー症候群 (GBS) などです。それにより、世界中の血漿交換市場にプラスの影響を与えています。 ただし、血漿交換療法は費用がかかるため、市場の成長を妨げる可能性があります。

世界の治療用血漿交換市場は、技術別、適応別、性別、最終用途別、地域別にセグメント化されています。適応別では、さらに神経障害、腎障害、血液障害、代謝障害に分けられ、慢性・致命的な神経障害の症例数が日々増加する中、神経障害が最も支配的なセグメントとなることが予想されます。

当レポートでは、世界の治療用血漿交換市場について調査分析し、市場規模・シェア・予測、セグメント別分析、競合分析、市場動向の変化、新興の機会について、体系的な情報を提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の治療用血漿交換市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 製品市場マップ

第6章 アジア太平洋地域の治療用血漿交換市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • アジア太平洋地域:国別分析

第7章 欧州の治療用血漿交換市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 欧州:国別分析

第8章 北米の治療用血漿交換市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 北米:国別分析

第9章 南米の治療用血漿交換市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 南米:国別分析

第10章 中東・アフリカの治療用血漿交換市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 中東・アフリカ:国別分析

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と動向

第13章 競合情勢

第14章 戦略的提言

第15章 出版社と免責事項

目次
Product Code: 4598

The global market for therapeutic plasma exchange is anticipated to grow at brisk rate during the forecast period. Therapeutic plasma exchange or plasmapheresis is a procedure to filter blood and remove harmful antibodies present in plasma by separating it from blood with the assistance of techniques called centrifugation or membrane separation. Therapeutic plasma exchange or Plasmapheresis, the process of replacing blood in the body, has witnessed significant rise in demand on account of increasing chronic diseases, for instance, Guillain Barre Syndrome (GBS); thereby, positively influencing the therapeutic plasma exchange market across the globe. However, plasmapheresis is costly enough, which is expected to hamper the growth of the market.

Global therapeutic plasma exchange market is segmented on the basis of technique, indication, gender, end use and region. Indication segment is further divided into neurological disorders, renal disorders, hematology disorders, metabolic disorders, out of which, neurological disorders is expected to be the most dominant segment as the number of cases of chronic and fatal neurological disorders are increasing day by day.

North America held the largest market share in the year of 2019 due to the pre-existing pharma & biotech companies and the surge in research and development activities in the region. On the other hand, Asia-Pacific is expected to be the fastest growing region as the leading companies of therapeutic plasma exchange in the region have now started investing in the plasmapheresis procedures.

Haemonetics Corporation, Fresenius Medical Care, Terumo BCT, Inc., Baxter International Inc., Asahi Kasei Medical Co., Ltd., Kawasumi Laboratories Inc., B. Braun Melsungen AG, HemaCare Corporation, Medica S.p.A., Cerus Corporation, Nikkiso Co., Ltd., Miltenyi Biotec, Therakos Incorporation, Fenwal Incorporation, Kaneka Corporation, etc., are some of the prominent therapeutic plasma exchange companies of the world. To maintain their position in the global therapeutic plasma exchange market, the leading players are adopting several organic and inorganic strategies such as mergers, acquisitions, etc.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and estimate the market size of global therapeutic plasma exchange market from 2015 to 2018.
  • To estimate and forecast the market size of global therapeutic plasma exchange market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global therapeutic plasma exchange market based on technique, indication, gender, end use, company and region.
  • To identify dominant region or segment in the global therapeutic plasma exchange market.
  • To identify drivers and challenges for global therapeutic plasma exchange market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global therapeutic plasma exchange market.
  • To conduct pricing analysis for global therapeutic plasma exchange market.
  • To identify and analyze the profile of leading players operating in global therapeutic plasma exchange market.
  • To identify key sustainable strategies adopted by market players in global therapeutic plasma exchange market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals and clinics using therapeutic plasma exchange techniques across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals and clinics using therapeutic plasma exchange techniques which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals and clinics using therapeutic plasma exchange techniques, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global therapeutic plasma exchange market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Hospitals, clinics, research organizations and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to therapeutic plasma exchange
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals and clinics using therapeutic plasma exchange techniques, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global therapeutic plasma exchange market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technique:

Centrifugation

Membrane Separation

  • Market, By Indication:

Neurological Disorders

Renal Disorders

Hematology Disorders

Metabolic Disorders

  • Market, By Gender:

Male

Female

  • Market, By End Use:

Hospitals

Clinics

Others

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Australia
  • Japan
  • South Korea

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global therapeutic plasma exchange market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Brand Awareness (Aided/Unaided)
  • 4.2. Product Awareness
  • 4.3. Customer Satisfaction Analysis
  • 4.4. Unmet Needs/Challenges

5. Global Therapeutic Plasma Exchange Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (Centrifugation v/s Membrane Separation)
    • 5.2.2. By Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders)
    • 5.2.3. By Gender (Male v/s Female)
    • 5.2.4. By End Use (Hospitals, Clinics, Others)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Therapeutic Plasma Exchange Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Indication
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Therapeutic Plasma Exchange Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By End Use
    • 6.3.2. India Therapeutic Plasma Exchange Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By End Use
    • 6.3.3. Australia Therapeutic Plasma Exchange Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By End Use
    • 6.3.4. Japan Therapeutic Plasma Exchange Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Technique
        • 6.3.4.2.2. By Indication
        • 6.3.4.2.3. By End Use
    • 6.3.5. South Korea Therapeutic Plasma Exchange Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Technique
        • 6.3.5.2.2. By Indication
        • 6.3.5.2.3. By End Use

7. Europe Therapeutic Plasma Exchange Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Indication
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Therapeutic Plasma Exchange Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By End Use
    • 7.3.2. Germany Therapeutic Plasma Exchange Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Therapeutic Plasma Exchange Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Therapeutic Plasma Exchange Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Therapeutic Plasma Exchange Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By End Use

8. North America Therapeutic Plasma Exchange Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Indication
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Therapeutic Plasma Exchange Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By End Use
    • 8.3.2. Mexico Therapeutic Plasma Exchange Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By End Use
    • 8.3.3. Canada Therapeutic Plasma Exchange Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By End Use

9. South America Therapeutic Plasma Exchange Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Indication
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Therapeutic Plasma Exchange Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By End Use
    • 9.3.2. Argentina Therapeutic Plasma Exchange Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By End Use
    • 9.3.3. Colombia Therapeutic Plasma Exchange Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By End Use

10. Middle East and Africa Therapeutic Plasma Exchange Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By Indication
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Therapeutic Plasma Exchange Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By End Use
    • 10.3.2. Saudi Arabia Therapeutic Plasma Exchange Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By End Use
    • 10.3.3. UAE Therapeutic Plasma Exchange Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Haemonetics Corporation
  • 13.2. Fresenius Medical Care
  • 13.3. Terumo BCT, Inc.
  • 13.4. Baxter International Inc.
  • 13.5. Asahi Kasei Medical Co., Ltd.
  • 13.6. Kawasumi Laboratories Inc.
  • 13.7. B. Braun Melsungen AG
  • 13.8. HemaCare Corporation
  • 13.9. Medica S.p.A.
  • 13.10. Cerus Corporation
  • 13.11. Nikkiso Co., Ltd.
  • 13.12. Miltenyi Biotec
  • 13.13. Therakos Incorporation
  • 13.14. Fenwal Incorporation
  • 13.15. Kaneka Corporation

14. Strategic Recommendations

15. About Us & Disclaimer

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.